New research may help doctors determine when (and when not) to test for antiglutamate decarboxylase antibodies in patients with neurological disorders and psychiatric symptoms.
Impact of Antiepileptic Medications and Sex Hormones on Maternal and Child Outcomes in Epilepsy
Episode 107: Revealing Mechanisms of Sudden Unexplained Death in Toddlers
Analysis on the Efficacy of Cenobamate in Pediatric Patients With Refractory Epilepsy
Episode 105: Recapping Conversations in Neurology From 2023
NeurologyLive® Brain Games: April 14, 2024
NeurologyLive® Friday 5 — April 12, 2024